293 related articles for article (PubMed ID: 9309091)
21. Advances in the treatment of patients with gastric adenocarcinoma.
Foukakis T; Lundell L; Gubanski M; Lind PA
Acta Oncol; 2007; 46(3):277-85. PubMed ID: 17450463
[TBL] [Abstract][Full Text] [Related]
22. [Preoperative neoadjuvant chemotherapy in esophago-cardial adenocarcinoma?].
Geissler M
Dtsch Med Wochenschr; 2006 Jun; 131(23):1344. PubMed ID: 16761207
[No Abstract] [Full Text] [Related]
23. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Miyata H; Monden M
J Surg Oncol; 2004 Oct; 88(1):39-43. PubMed ID: 15384086
[TBL] [Abstract][Full Text] [Related]
24. Transhiatal esophagectomy for distal and cardia cancers: implications of a positive gastric margin.
DiMusto PD; Orringer MB
Ann Thorac Surg; 2007 Jun; 83(6):1993-8; discussion 1998-9. PubMed ID: 17532385
[TBL] [Abstract][Full Text] [Related]
25. [Multimodal therapy in patients with advanced gastric cancer].
Otto F
MMW Fortschr Med; 2008 May; 150(19):31-3. PubMed ID: 18589912
[No Abstract] [Full Text] [Related]
26. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
27. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
28. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
Bittoni A; Maccaroni E; Scartozzi M; Berardi R; Cascinu S
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):309-14. PubMed ID: 20496540
[TBL] [Abstract][Full Text] [Related]
30. Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma.
Bar-Sela G; Tsalic M; Steiner M; Wollner M; Haim N
Anticancer Res; 2009 May; 29(5):1853-6. PubMed ID: 19443416
[TBL] [Abstract][Full Text] [Related]
31. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
Grau JJ; Martín M; Fuster J; Pera M; García-Valdecasas JC; Bombí JA; Bordas JM; Alcobendas F; Grande L; Estapé J
J Surg Oncol; 2003 Apr; 82(4):234-40. PubMed ID: 12672007
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
[TBL] [Abstract][Full Text] [Related]
33. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey.
Tiberio GA; Coniglio A; Marchet A; Marrelli D; Giacopuzzi S; Baiocchi L; Roviello F; de Manzoni G; Nitti D; Giulini SM
Eur J Surg Oncol; 2009 May; 35(5):486-91. PubMed ID: 19171450
[TBL] [Abstract][Full Text] [Related]
34. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
35. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
[TBL] [Abstract][Full Text] [Related]
36. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
Rosen H
Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
[TBL] [Abstract][Full Text] [Related]
37. [Current state of treatment for advanced gastric cancer].
Kato K; Kiyokawa T; Mori K; Fukuda T; Hatao F; Abe M; Ueda T; Wada I; Shimizu N; Nomura S; Seto Y
Gan To Kagaku Ryoho; 2011 Feb; 38(2):184-6. PubMed ID: 21368481
[TBL] [Abstract][Full Text] [Related]
38. [A case of stage IV advanced gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy which leads to a pathological complete response].
Hiraoka K; Mizutani S; Oyama T; Uchikoshi F; Yoshidome K; Tori M; Ueshima S; Yamagami Y; Takahashi H; Nakahara M; Tsujimoto M
Gan To Kagaku Ryoho; 2007 Jan; 34(1):93-5. PubMed ID: 17220679
[TBL] [Abstract][Full Text] [Related]
39. A rare case of alpha-fetoprotein-producing early gastric cancer.
Shimoyama S; Nozaki K; Kaminishi M; Motoi N; Murakami T
Hepatogastroenterology; 2001; 48(39):687-91. PubMed ID: 11462904
[TBL] [Abstract][Full Text] [Related]
40. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy.
Jeung HC; Rha SY; Jang WI; Noh SH; Chung HC
Br J Surg; 2002 Apr; 89(4):460-6. PubMed ID: 11952588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
